ISPOR Introduces Corporate Partner Program

Published Feb 25, 2025
New Corporate Partner Program Provides Comprehensive, Year-Round Engagement With the Global HEOR Audience

Lawrenceville, NJ, USA—February 25, 2025—ISPOR—The Professional Society for Health Economics and Outcomes Research announced its new ISPOR Corporate Partnership Program that is designed to provide organizations with comprehensive, year-round engagement with the global health economics and outcomes research (HEOR) audience.

ISPOR’s Corporate Partnership Program supports the Society’s mission to advance HEOR excellence to improve decision making for health globally. In alignment with its Strategic Plan 2030, ISPOR and its corporate partners will work together to:

  • Advance HEOR knowledge and innovation by promoting cutting-edge research, education, and training initiatives
  • Enhance health outcomes by driving the development and implementation of evidence-based healthcare policies and practices worldwide
  • Strengthen the global HEOR community by fostering a vibrant and inclusive professional community

A number of prominent organizations have joined the ISPOR Corporate Partner Program as inaugural members and include:

  • Aetion
  • Analysis Group
  • Cencora
  • Evidera
  • Genesis Research Group
  • OPEN Health
  • Premier

ISPOR’s Corporate Partnership Program offers a unique opportunity for organizations to:

  • Elevate visibility by gaining exposure to a global audience of influential HEOR experts.
  • Drive innovation and HEOR excellence through collaborative discussions and thought leadership.
  • Contribute toward improving health globally by supporting initiatives that improve patients’ health outcomes.

ISPOR CEO, Rob Abbott, stated, “We are very excited to launch the new Corporate Partner Program and invite organizations to contribute to ISPOR’s vision of a world where healthcare is accessible, effective, efficient, and affordable for all. Organizations who become ISPOR Corporate Partners will take an active role in the Society’s mission to improve healthcare decisions and achieving this vision, while elevating their presence with key stakeholders.”

Additional information can be found on the ISPOR Corporate Partnerships webpage.

###

 

ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research
(HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website
 | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram 

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Europe 2025 Plenaries and Speakers Announced

Oct 13, 2025

ISPOR announced details for its ISPOR Europe 2025. The conference is the leading global conference in Europe for health economics and outcomes research (HEOR) and is scheduled for 9-12 November in Glasglow, Scotland, UK with the theme, “Powering Value and Access Through Patient-Centered Collaboration.”
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×